oral tirzepatide fda approved approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Lilly weight-loss pill orforglipron could

Hormone Replacement Therapy may help with hair loss when thinning is linked to low estrogen, progesterone, or testosterone imbalance

Briefly, aliquots of 250 L were taken of each urine culture and diluted with pure methanol (1:3 for clinical samples and 1:6 for the in vitro analysis), vortexed, incubated on ice for 30 min, and centrifuged at x16000 g for 10 min

ONCOLOGY Vol 39, Issue 7 Volume 39 Issue 7 Pages: 294-296 GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer Sherry Shen, MD , Bethina Liu, MD , Chad Fanti, MD Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population

Retinoids such as retinol also have anti-inflammatory effects on the skin [14]

Because the side effects that you mentioned are pretty serious

Generic semaglutide versions are expected in India from 2026 onwards after Novo Nordisks patent expires